Skip to main content
Clinical Trials/NL-OMON31154
NL-OMON31154
Completed
Phase 4

ser evaluation of the 'free style Navigator continuous glucose monitoring system - Navigator continuous glucose monitoring system

Abbott0 sites20 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
diabetes mellitus
Sponsor
Abbott
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Abbott

Eligibility Criteria

Inclusion Criteria

  • Type 1 diabetes mellitus since at least 2 jaar
  • Age at least 18 years

Exclusion Criteria

  • 1: Severe hypoglycaemia during the last 4 months before the start of the study
  • 2: Medical problems (co\-morbidity, organ complications of diabetes) of medication
  • that would potentially jeopardize the participation of the patient in the eyes of
  • the treating physician and/or the investigator
  • 3: Pregnancy or planned pregnancy during the study period
  • 4: Participation in another study with a comparable device

Outcomes

Primary Outcomes

Not specified

Similar Trials